drugset / Trial / NCT00263133

Modulation of Visually Evoked Potentials by an Antidepressant

NCT00263133

Completed 12 enrolled University Hospital Freiburg
Non-randomizedSingle-groupOpen-labelTreatment

Summary

12 normal healthy controls will be treated with 50 mg sertraline once daily for three weeks. Early amplitudes of visually evoked potentials will be examined at day 0, 10 and 21 and statistically compared. This study aims to examine a putative modulation of synaptic transmission and plasticity by an antidepressant and is part of a series of studies in healthy individuals and depressed patients.

Timeline

Start
2005-12
Primary completion
Completion
2006-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Sertraline Small molecule 50 mg

Indications